Who has invested in Georgiamune?

General Catalyst, Parker Institute for Cancer Immunotherapy are named among the investors backing Georgiamune.

Georgiamune Funding: $75M Raised, Investors & Rounds

Georgiamune has raised $75M in total funding. Backed by General Catalyst, Parker Institute for Cancer Immunotherapy.

Georgiamune funding overview

Georgiamune has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Georgiamune runs through 2023; nothing later has been disclosed. Investors on record include General Catalyst, Parker Institute for Cancer Immunotherapy. 2 distinct backers are named across the disclosed rounds.

Georgiamune at a glance

Total raised: $75M
Latest round date: August 2023
Notable investors: General Catalyst, Parker Institute for Cancer Immunotherapy

Frequently asked about Georgiamune funding

How much has Georgiamune raised?: Georgiamune has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Georgiamune?: General Catalyst, Parker Institute for Cancer Immunotherapy are named among the investors backing Georgiamune.
What was the latest Georgiamune funding round?: No round stage has been disclosed for Georgiamune.
Where is Georgiamune based?: No headquarters location is disclosed for Georgiamune.
When did Georgiamune last raise?: The last disclosed Georgiamune round closed in August 2023.

Totals shown for Georgiamune aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.

Georgiamune pitch deck

The investor deck Georgiamune used to raise — 2023, Series A, 20-slide deck is broken down slide by slide, including the slides it leads with and the questions it leaves open.

Companies related to Georgiamune (18)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026